浅谈高压变频调速变压器及高压变频系统结构

介绍了高压变频调速变压器及高压变频器系统的基本原理及结构,详细论述了系统各组成部分的功能,并进行了举例说明。     

Unsupervised regions based segmentation using object discovery

We present a new unsupervised algorithm to discovery and segment out common objects from multiple images. Compared with previous cosegmentation methods, our algorithm performs well even when the appearance variations in the foregrounds are more substantial than those in some areas of the backgrounds. Our algorithm mainly includes two parts: the foreground object discovery scheme and the iterative region allocation algorithm. Two terms, a region-saliency prior and a region-repeatness measure, are introduced in the foreground object discovery scheme to detect the foregrounds without any supervisory information. The iterative region allocation algorithm searches the optimal solution for the final segmentation with the constraints from a maximal spanning tree, and an effective color-based model is utilized during this process. The comparative experimental results show that the proposed algorithm matches or outperforms several previous methods on several standard datasets.     

In-vitro and in-vivo comparison of T-OA microemulsions and solid dispersions based on EPDC

The goal of this study was to enhance the absorption of a new water-insoluble antitumor lead compound, T-OA (3β-hydroxyolea-12-en-28-oic acid-3, 5, 6-trimethylpyrazin-2-methyl ester). Early-stage preparation discovery concept (EPDC) was employed in this study. Based on this concept, a microemulsion system was chosen as the method of improving bioavailability. The solubility of T-OA was checked in different oils, surfactants and cosurfactants. Ternary phase diagrams were constructed to evaluate the microemulsion domain. Developed high-performance liquid chromatography method was used to determine drug content. The transparent o/w microemulsion formulation composed of oleic acid (oil), Tween 80 (surfactant), ethanol (co-surfactant) and water enhanced the solubility of T-OA up to 20?mg/mL. It was characterized in terms of appearance, content, viscosity, zeta potential, conductivity, morphology and particle size. The particle size distribution, viscosity, conductivity and zeta potential were found to be 70?nm, 15.57?MPa?s, 44.1?μS?cm^?1 and ?0.174, respectively. Oral bioavailability of T-OA microemulsion and oleic acid solution were checked by using rat model. Contrast to the solid dispersion and proto drug, the area-under-the-curve (AUC) of T-OA microemulsion and oleic acid solution were significantly enhanced. The relative bioavailability of T-OA microemulsion was found to be 5654.7%, which is 57-fold higher than the pure drug. Improved T-OA solubility in microemulsion was found sustained 48?h in dilution study. While the solid dispersion may precipitate under the gastrointestinal circumstance based on dilution results. The in-vivo and in-vitro results indicated that, compare to improve the solubility, it is more important to maintain and prolong the T-OA dissolved status, for improvement of the in-vivo absorption.     

金华地区电力通信基础网运维现状分析及维护建议

针对金华地区电力通信基础网的拓扑现状,结合地区网络发展的需求,讨论了基础网传输系统拓扑结构和运维现状存在的设备异常、板卡资源紧张、合理接入等问题,并就金华地区基础网系统拓扑结构层次的合理优化以及运行维护提出可行性建议。     

折臂式随车起重机转台的拓扑优化设计

为了使折臂式随车起重机转台在最大应力不超过材料许用应力的前提下实现轻量化设计的目的,通过ADAMS软件仿真确定其极限工况,对转台进行静力学分析及拓扑优化。通过拓扑优化得到了理想的材料分布。基于优化结果调整转台结构,并对改进后的转台进行静力学分析。结果表明,优化后的转台能够满足实际的使用需求。同时,转台质量降低了12%,证明了优化设计的有效性和可行性,并为折臂式随车起重机的相关设计提供了一定的借鉴。     

Three-phased clustered topology formation for Aeronautical Ad-Hoc Networks

In-Flight Internet Connectivity (IFC) has become one of the crucial needs of passengers with technological improvements. The Aeronautical Ad-hoc Networks (AANETs) have been proposed by establishing air-to-air (A2A) links between aircraft to satisfy this need. However, the unstructured aircraft topology caused by their ultra-dynamic characteristics reduces the longevity of A2A links in AANET. This shorter longevity decreases the stability of AANET by accelerating the connection establishment/termination procedures between aircraft. Additionally, the shorter link longevity affects the packet transfer delay and the delivery ratio of AANET. To the best of our knowledge, these three challenges are not investigated simultaneously under one topology management model. This paper proposes a three-phased topology formation model for AANETs to increase the stability and packet delivery ratio in AANET with a shorter packet transfer delay. The first phase corresponds to the aircraft clustering formation, and here, we aim to increase the AANET stability by creating spatially correlated clusters. The second phase consists of the A2A link determination for reducing the packet transfer delay. Finally, the cluster head selection increases the packet delivery ratio in AANET. According to our simulations, we see that the stability and packet delivery ratio of AANET topology are roughly improved 35% and 31% with a 28% delay reduction compared to the methods in the literature.     

Small-Molecule Inhibition of Glucose Transporters GLUT-1–4

Glucose addiction is observed in cancer and other diseases that are associated with hyperproliferation. The development of compounds that restrict glucose supply and decrease glycolysis has great potential for the development of new therapeutic approaches. Addressing facilitative glucose transporters (GLUTs), which are often upregulated in glucose-dependent cells, is therefore of particular interest. This article reviews a selection of potent, isoform-selective GLUT inhibitors and their biological characterization. Potential therapeutic applications of GLUT inhibitors in oncology and other diseases that are linked to glucose addiction are discussed.     

A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea,Ameliorates Experimental Autoimmune Encephalomyelitis

Polyunsaturated fatty acids (PUFAs) are essential FAs for human health. Cytochrome P450 oxygenates PUFAs to produce anti-inflammatory and pain-resolving epoxy fatty acids (EpFAs) and other oxylipins whose epoxide ring is opened by the soluble epoxide hydrolase (sEH/Ephx2), resulting in the formation of toxic and pro-inflammatory vicinal diols (dihydroxy-FAs). Pharmacological inhibition of sEH is a promising strategy for the treatment of pain, inflammation, cardiovascular diseases, and other conditions. We tested the efficacy of a potent, selective sEH inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), in an animal model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE). Prophylactic TPPU treatment significantly ameliorated EAE without affecting circulating white blood cell counts. TPPU accumulated in the spinal cords (SCs), which was correlated with plasma TPPU concentration. Targeted lipidomics in EAE SCs and plasma identified that TPPU blocked production of dihydroxy-FAs efficiently and increased some EpFA species including 12(13)-epoxy-octadecenoic acid (12(13)-EpOME) and 17(18)-epoxy-eicosatrienoic acid (17(18)-EpETE). TPPU did not alter levels of cyclooxygenase (COX-1/2) metabolites, while it increased 12-hydroxyeicosatetraenoic acid (12-HETE) and other 12/15-lipoxygenase metabolites. These analytical results are consistent with sEH inhibitors that reduce neuroinflammation and accelerate anti-inflammatory responses, providing the possibility that sEH inhibitors could be used as a disease modifying therapy, as well as for MS-associated pain relief.     

Discovery of GPR183 Agonists Based on an Antagonist Scaffold

The G protein-coupled receptor GPR183/EBI2, which is activated by oxysterols, is a therapeutic target for inflammatory and metabolic diseases where both antagonists and agonists are of potential interest. Using the piperazine diamide core of the known GPR183 antagonist (E)-3-(4-bromophenyl)-1-(4-(4-methoxybenzoyl)piperazin-1-yl)prop-2-en-1-one (NIBR189) as starting point, we identified and sourced 79 structurally related compounds that were commercially available. In vitro screening of this compound collection using a Ca²⁺ mobilization assay resulted in the identification of 10 compounds with agonist properties. To enable establishment of initial structure-activity relationship trends, these were supplemented with five in-house compounds, two of which were also shown to be GPR183 agonists. Taken together, our findings suggest that the agonist activity of this compound series is dictated by the substitution pattern of one of the two distal phenyl rings, which functions as a molecular efficacy-switch.